Claudio Espejo Acuña MD, MBA
PORTFOLIO
A whole spectrum of services provided for public and private institutions, as well as for the general population
Portfolio of services according to the type of institution
Preparation of updated scientific-medical information based on evidence
Review of current medical data
State of the Art documents preparation on clinical and therapeutics affairs
Updated clinical guidelines analysis focused on cardio-renal-metabolic diseases, hypertension and internal medicine
Advanced analysis of relevant clinical topics
Evaluation and discussion of emergent controversial clinical aspects
Current unmet clinical needs evaluation and up-to-date
Experts and KOLs´s opinion summary on relevant clinical themes
Novel therapeutics evaluation (pros/cons)
Data generation to support the pharmaceutical promotional efforts
Promotional medical messages generation based on evidence
Bibliographic support generation
Relevant clinical data identification for drugs´s portfolios
Evidence-based medicine analysis of main pharma-market competitors
Workshops, seminars, and conferences data show construction
Essential concepts draft preparation
Slide-kits generation
Production of audiovisual material and tutorials
Educational materials elaboration focused on general audiences to support public campaigns
Educative tools creation focused on the most relevant pathologies encountered in the general population
Advisory on promotional materials preparation (i.e. flyers)
Consulting on community health preventive campaigns
Audio-visual material
Interactive evaluation/educational programmes
Evidence-based novel therapies up-to-date
Continuous new drug searching
New pharmacotherapies strengths and weaknesses analysis
Novel Therapies' competitive status definition within their natural market
Gaps identification in the general contemporary medication arsenal
Diseases and drugs review preparation
Evidence-based updated reviews on pathologies and medications
Bibliographic support construction
VAPs preparation
Advisory on value-added programs construction to patients according to specific diseases
Deliverable resources proposal (specific contents)
Medical Affairs approach
Medical affairs evaluation, analysis, and recommendations
Medical advisory to multifunction teams
Medical support to Bio-pharmaceutical & Biotechnological MKT / Sales teams
Support to the public health sector
Medical Q & A script development
Expert board constitution
Drugs safety profile definition
Support to pharmacovigilance teams
Medical advisory on adverse events analysis
Bibliographic support on adverse events’ detection
Medical strategic & tactic support to MARKETING Brand Plans
Delivery of scientific/medical recommendations
Support to the competitor´s brand analysis
SWOT evaluation
Think-tank leadership with MKT/Commercial teams
Evaluation of promotional materials focused on medical audiences
Advisory on tools generation (ethical, balanced, and precise)
Theoretical back-up based on evidence
Current Medical Concepts Introduction within the promotional platform
Field Force training
Study tools development
Up to date of former training materials
Training slide-kits preparation
Study assessment materials development
Training workshops
Medical Q&A guide construction
Training & Medical Advisory to commercial/MARKETING executives
Support material construction
Training sessions according to team needs
Medical audience's key issues resolution
Capitalising on needs, seeking solutions
Medical-scientific analysis of drug portfolios
Medical-scientific essentials development to provide the medicines positioning within the market
The drug´s lifecycle assessment based on updated bio-medical data
Drug´s portfolio SWOT development
Q&A script construction
Medicine´s portfolio strategic approach, according to the market situation (lifecycle, SWOT, positioning)
GP’s medical training
Talk´s slides preparation
Seminars and clinical scenarios to discuss development
Round tables and think tanks leadership
Healthcare opportunities detection from basic research
Basic science data continuous checking
Profiling opportunities to develop new medicines
Learning about AI´s advances in healthcare
Working together with scientific teams
Delivering cooperation to multidisciplinary biomedical scientific teams
Continuous medical education program development
